3 结果
FIELD OF THE INVENTION
This invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) and combinations of the phytocannabinoid CBDV with tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy. The invention further relates to the use of the phytocannabinoid
RELATED APPLICATION
This application is a national stage filing under 35 U.S.C. .sctn. 371 of international application PCT/GB2012/052284, filed Sep. 14, 2012, which was published under PCT Article 21(2) in English.
This invention relates to a pharmaceutical composition comprising or consisting
This application is a National Stage application under 35 U.S.C. .sctn. 371 of International Application No. PCT/GB2017/050868, having an International Filing Date of Mar. 28, 2017, which claims the benefit of United Kingdom Application Serial No. 1605448.8 filed Mar. 31, 2016. This disclosure of